Articles with public access mandates - Erik Roberson - Canadian Institutes of Health ResearchLearn more
NoteFor this mandate, articles should be available from specific locations.
OverallNIHCIHRDoDMRCWellcomeHHMIVANSFCSwedish Research CouncilAlzheimers's UKNIHRGovernment of SpainNSFNWOEuropean CommissionZonMwGovernment of ItalyFWODFGAcademy of FinlandINSERMParkinson's UKBMBFMichael J Fox FoundationParkinson's Foundation, USAMarianne and Marcus Wallenberg FoundationDMTMotor Neurone Disease Association, UKState of CalifoniaAXA Research Fund, FranceBrain Research, UKSNSFAHAFWFARCNHMRCNSERCHelmholtzBanking Foundation "la Caixa"Knut and Alice Wallenberg FoundationANRPCORINMRCJDRFFlorida Department of Health, USABELSPOCZI
Available based on mandate: 38
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease
AC Naj, G Jun, GW Beecham, LS Wang, BN Vardarajan, J Buros, ...
Nature genetics 43 (5), 436-441, 2011
Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis
Y Iturria-Medina, RC Sotero, PJ Toussaint, JM Mateos-Pérez, AC Evans
Nature communications 7 (1), 11934, 2016
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
R Sims, SJ Van Der Lee, AC Naj, C Bellenguez, N Badarinarayan, ...
Nature genetics 49 (9), 1373-1384, 2017
Plasma tau in Alzheimer disease
N Mattsson, H Zetterberg, S Janelidze, PS Insel, U Andreasson, ...
Neurology 87 (17), 1827-1835, 2016
Ferritin levels in the cerebrospinal fluid predict Alzheimer’s disease outcomes and are regulated by APOE
S Ayton, NG Faux, AI Bush
Nature communications 6 (1), 6760, 2015
Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial
AL Boxer, AE Lang, M Grossman, DS Knopman, BL Miller, LS Schneider, ...
The Lancet Neurology 13 (7), 676-685, 2014
Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer’s pathology
TW Schmitz, R Nathan Spreng
Nature communications 7 (1), 13249, 2016
A novel Alzheimer disease locus located near the gene encoding tau protein
G Jun, CA Ibrahim-Verbaas, M Vronskaya, JC Lambert, J Chung, AC Naj, ...
Molecular psychiatry 21 (1), 108-117, 2016
Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study
AC Naj, G Jun, C Reitz, BW Kunkle, W Perry, YS Park, GW Beecham, ...
JAMA neurology 71 (11), 1394-1404, 2014
Transethnic genome‐wide scan identifies novel Alzheimer's disease loci
GR Jun, J Chung, J Mez, R Barber, GW Beecham, DA Bennett, ...
Alzheimer's & Dementia 13 (7), 727-738, 2017
Bayesian model reveals latent atrophy factors with dissociable cognitive trajectories in Alzheimer’s disease
X Zhang, EC Mormino, N Sun, RA Sperling, MR Sabuncu, BTT Yeo, ...
Proceedings of the National Academy of Sciences 113 (42), E6535-E6544, 2016
Alzheimer disease brain atrophy subtypes are associated with cognition and rate of decline
SL Risacher, WH Anderson, A Charil, PF Castelluccio, S Shcherbinin, ...
Neurology 89 (21), 2176-2186, 2017
Prediction and classification of Alzheimer’s disease based on combined features from apolipoprotein-E genotype, cerebrospinal fluid, MR, and FDG-PET imaging biomarkers
Y Gupta, RK Lama, GR Kwon, ...
Frontiers in computational neuroscience 13, 72, 2019
Robust identification of Alzheimer’s disease subtypes based on cortical atrophy patterns
JY Park, HK Na, S Kim, H Kim, HJ Kim, SW Seo, DL Na, CE Han, ...
Scientific reports 7 (1), 43270, 2017
Heterogeneous cortical atrophy patterns in MCI not captured by conventional diagnostic criteria
EC Edmonds, J Eppig, MW Bondi, KM Leyden, B Goodwin, ...
Neurology 87 (20), 2108-2116, 2016
Plasma neurofilament light for prediction of disease progression in familial frontotemporal lobar degeneration
JC Rojas, P Wang, AM Staffaroni, C Heller, Y Cobigo, A Wolf, SYM Goh, ...
Neurology 96 (18), e2296-e2312, 2021
Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer’s disease cohorts
L Tan, HF Wang, MS Tan, CC Tan, XC Zhu, D Miao, WJ Yu, T Jiang, L Tan, ...
Scientific reports 6 (1), 26027, 2016
Use of the CDR® plus NACC FTLD in mild FTLD: data from the ARTFL/LEFFTDS consortium
T Miyagawa, D Brushaber, J Syrjanen, W Kremers, J Fields, LK Forsberg, ...
Alzheimer's & Dementia, 2019
Holocranohistochemistry enables the visualization of α-synuclein expression in the murine olfactory system and discovery of its systemic anti-microbial effects
JJ Tomlinson, B Shutinoski, L Dong, F Meng, D Elleithy, NA Lengacher, ...
Journal of neural transmission 124, 721-738, 2017
Mining outcome-relevant brain imaging genetic associations via three-way sparse canonical correlation analysis in Alzheimer’s disease
X Hao, C Li, L Du, X Yao, J Yan, SL Risacher, AJ Saykin, L Shen, ...
Scientific reports 7 (1), 44272, 2017
Publication and funding information is determined automatically by a computer program